Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 2
2021 3
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Striving toward hepatitis C elimination in the era of COVID-19.
Lanièce Delaunay C, Greenwald ZR, Minoyan N, Artenie AA, Jeong D, Marathe G, Saeed YA, Kolla G, Kunden RD, Okwor CIA, Wallace HL, Mendlowitz A, Liu CH, Mazouz S, D'souza S, Perciani CT, Rheault M, Palmer MA, Palayew A, Abdelnabi MN, Cunningham EB. Lanièce Delaunay C, et al. Can Liver J. 2021 Feb 24;4(1):4-7. doi: 10.3138/canlivj-2020-0027. eCollection 2021 Winter. Can Liver J. 2021. PMID: 35991473 Free PMC article. No abstract available.
Impacts of the COVID-19 pandemic on hepatitis C elimination in Canada: Where do we go from here?
Atif J, Udhesister STP, Abdelnabi MN, D'Souza S, Hung JH, Edgar RD, Gobran ST, Gomez-Escobar E, Greenwald ZR, Gallardo-Flores CE, Fontaine G, Jeong D, Lanièce-Delaunay C, Lawton D, Makuza JD, Masterman C, Marathe G, Mortazhejri S, Li J, Palmer M, Passos-Castilho AM, Sag M, Shengir M, Wallace HL, Mendlowitz AB; 2022–2023 trainees of the Canadian Network on Hepatitis C. Atif J, et al. Among authors: laniece delaunay c. Can Liver J. 2022 Nov 7;5(4):441-444. doi: 10.3138/canlivj-2022-0035. eCollection 2022 Nov. Can Liver J. 2022. PMID: 38144406 Free PMC article. No abstract available.
Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
Lanièce Delaunay C, Maheu-Giroux M, Marathe G, Saeed S, Martel-Laferrière V, Cooper CL, Walmsley S, Cox J, Wong A, Klein MB; Canadian Coinfection Cohort investigators. Lanièce Delaunay C, et al. Int J Drug Policy. 2022 May;103:103627. doi: 10.1016/j.drugpo.2022.103627. Epub 2022 Feb 24. Int J Drug Policy. 2022. PMID: 35218989 Free article.
Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada.
Marathe G, Moodie EEM, Brouillette MJ, Lanièce Delaunay C, Cox J, Martel-Laferrière V, Gill J, Cooper C, Pick N, Vachon ML, Walmsley S, Klein MB; Canadian Co-Infection Cohort. Marathe G, et al. Among authors: laniece delaunay c. Clin Infect Dis. 2023 Feb 8;76(3):e702-e709. doi: 10.1093/cid/ciac540. Clin Infect Dis. 2023. PMID: 35789253 Free PMC article.
Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study.
Lanièce Delaunay C, Klein MB, Godin A, Cox J, Kronfli N, Lebouché B, Doyle C, Maheu-Giroux M. Lanièce Delaunay C, et al. Int J Drug Policy. 2023 Jun;116:104026. doi: 10.1016/j.drugpo.2023.104026. Epub 2023 Apr 7. Int J Drug Policy. 2023. PMID: 37075626 Free PMC article.
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Lanièce Delaunay C, Martínez-Baz I, Sève N, Domegan L, Mazagatos C, Buda S, Meijer A, Kislaya I, Pascu C, Carnahan A, Oroszi B, Ilić M, Maurel M, Melo A, Sandonis Martín V, Trobajo-Sanmartín C, Enouf V, McKenna A, Pérez-Gimeno G, Goerlitz L, de Lange M, Rodrigues AP, Lazar M, Latorre-Margalef N, Túri G, Castilla J, Falchi A, Bennett C, Gallardo V, Dürrwald R, Eggink D, Guiomar R, Popescu R, Riess M, Horváth JK, Casado I, García MDC, Hooiveld M, Machado A, Bacci S, Kaczmarek M, Kissling E; European Primary Care Vaccine Effectiveness Group. Lanièce Delaunay C, et al. Euro Surveill. 2024 Mar;29(13):2300403. doi: 10.2807/1560-7917.ES.2024.29.13.2300403. Euro Surveill. 2024. PMID: 38551095 Free PMC article.
Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study.
Diallo MSK, Rabilloud M, Ayouba A, Touré A, Thaurignac G, Keita AK, Butel C, Kpamou C, Barry TA, Sall MD, Camara I, Leroy S, Msellati P, Ecochard R, Peeters M, Sow MS, Delaporte E, Etard JF; Contactebogui Study Group. Diallo MSK, et al. Lancet Infect Dis. 2019 Mar;19(3):308-316. doi: 10.1016/S1473-3099(18)30649-2. Epub 2019 Feb 11. Lancet Infect Dis. 2019. PMID: 30765243
12 results